Tonix Pharmaceuticals Holding Corp. (TNXP)
Tonix Pharmaceuticals Holding Corp. is a biopharmaceutical firm primarily operating in the clinical development stage. Its overarching mission involves the discovery, acquisition, advancement, and commercialization of novel therapeutic agents and diagnostic tools, all aimed at combating human illnesses and easing patient discomfort. The company boasts a comprehensive pipeline of potential treatments spanning several key medical fields: immunology, rare conditions, infectious diseases, and central nervous system (CNS) disorders. In the realm of immunology, Tonix is progressing with biologics designed to address organ transplant rejection, various autoimmune diseases, and certain forms of cancer. A prominent candidate here is TNX-1500, a humanized monoclonal antibody targeting CD40-ligand, which is being investigated for its utility in preventing both allograft and xenograft rejection, as well as in treating autoimmune disorders. Its rare disease initiatives include TNX-2900, a specific treatment candidate for Prader-Willi syndrome. The infectious disease segment features a diverse array of programs: TNX-801, a vaccine designed to offer protection against smallpox and monkeypox. TNX-1840 and TNX-1850, which are live virus vaccines based on the company's recombinant pox vaccine (RPV) platform, targeting COVID-19. TNX-3500, a small molecule antiviral drug for the treatment of acute COVID-19. TNX-102 SL, a small molecule medication under investigation for Long COVID, a persistent post-acute COVID-19 condition. Finally, the CNS portfolio encompasses both small molecules and biologics intended to manage pain, neurological conditions, psychiatric ailments, and addiction. Notably, TNX-102 SL is also in mid-Phase 3 development for alleviating fibromyalgia symptoms. Other CNS candidates include TNX-1900, which is being developed to prevent migraine headaches, and TNX-1300, a biologic aimed at treating cocaine intoxication. The company was established in 2007 and maintains its headquarters in Chatham, New Jersey.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Tonix Pharmaceuticals Holding Corp.
NASDAQ:TNXPHealthcare · Biotechnology
-3.41%$5.10
AH$5.11+0.20%vs close
Mkt Cap$87.47M
Float17.11M
O/S17.15M
Vol
$ Vol
RVOL
Inst Own55.2%
Earnings
Dilution
Financials Summary
Revenue$13.11M
Net Income-$124.02M
Total Assets$277.17M
Free Cash Flow-$103.21M
Debt & Equity
Debt 1%
Equity 99%
Total Debt$1.31M
Total Equity$245.15M
Shares Outstanding
Short Interest
Split History8 splits · 8 reverse
2-year cumulative
1:100
Nasdaq bars a compliance period at 1:250
- 1:100Reverse splitFeb 5, 2025100 shares → 1
- 1:32Reverse splitJun 10, 202432 shares → 1
- 1:6.3Reverse splitMay 10, 20236.3 shares → 1
- 1:32Reverse splitMay 17, 202232 shares → 1
- 1:10Reverse splitNov 1, 201910 shares → 1
- 1:10Reverse splitNov 28, 201810 shares → 1
- 1:10Reverse splitMar 17, 201710 shares → 1
- 1:20Reverse splitMay 1, 201320 shares → 1
Balance Sheet Details
Assets$277.17M
Liabilities$32.02M
Accounts Receivable$9.76M
Accounts Payable$8.11M
Inventory$6.01M
PP&E (Net)$46M
Goodwill$0
Intangible Assets$120K
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 |
| Revenue | $13.11M | $10.09M | $7.77M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | 29.8% | 29.9% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Revenue | $8.56M | $7.76M | $4.74M | $0 | $0 | $27K | $0 | $26.32M | $21.29M | $38.97M | $48.16M | $27.66M | $10.89M | $6.66M | $3.38M | $0 | $17K | $7K |
| Gross Profit | $4.54M | $2.33M | $3.03M | $0 | $0 | -$27K | $0 | -$26.32M | -$21.29M | -$38.97M | -$48.16M | -$27.66M | -$10.89M | -$6.66M | -$3.38M | $0 | -$17K | -$7K |
| Gross Margin | 34.7% | 23.1% | 39.0% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Research and Development | $44.49M | $40.45M | $86.66M | $81.88M | $68.84M | $36.16M | $18.19M | $17.56M | $13.34M | $28.53M | $35.5M | $18.62M | $4.65M | $2.58M | $1.16M | $0 | $0 | $0 |
| Selling, General, and Administrative | $85.76M | $40.1M | $34.75M | $30.21M | $23.47M | $14.33M | $10.64M | $8.76M | $7.95M | $10.44M | $12.66M | $9.04M | $6.24M | $4.08M | $2.22M | $14K | $14K | $14K |
| Other | $0 | $58.48M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $2K | $0 | $4K | $0 | $0 |
| Total Operating Expenses | $130.25M | $139.03M | $121.41M | $112.09M | $92.31M | $50.48M | $28.83M | $26.32M | $21.29M | $38.97M | $48.16M | $27.66M | $10.89M | $6.66M | $3.38M | $18K | $14K | $14K |
| Operating Income (EBIT) | -$125.7M | -$136.7M | -$118.38M | -$112.09M | -$92.31M | -$50.51M | -$28.83M | -$26.32M | -$21.29M | -$38.97M | -$48.16M | -$27.66M | -$10.89M | -$6.66M | -$3.38M | -$18K | -$31K | -$21K |
| Operating Margin | -959.1% | -1354.3% | -1523.9% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Expense | $89K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $4K | $1.61M | $0 | $0 | $0 | $0 |
| Interest Income | $4.15M | $0 | $0 | $1.87M | $25K | $48K | $0 | $233K | $168K | $127K | $108K | $40K | $4K | $0 | $0 | $0 | $0 | $0 |
| Other Income (Expense) | $1.68M | $6.67M | $1.72M | $1.87M | $25K | $48K | $210K | $233K | $168K | $127K | $108K | $40K | $4K | -$2.79M | -$92K | -$1.94M | $0 | $0 |
| Income Before Tax (EBT) | -$124.02M | -$130.04M | -$116.66M | -$110.22M | -$92.29M | -$50.46M | -$28.62M | -$26.09M | -$21.12M | -$38.84M | -$48.05M | -$27.62M | -$10.88M | -$9.45M | -$3.47M | $0 | $0 | $0 |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $233K | -$70K | -$206K | -$161K | -$36K | -$17K | $1.61M | $0 | $18K | $31K | $21K |
| Net Income | -$124.02M | -$130.04M | -$116.66M | -$110.22M | -$92.29M | -$50.46M | -$28.62M | -$29.36M | -$21.12M | -$38.84M | -$48.05M | -$27.62M | -$10.88M | -$9K | -$3.47M | -$18K | -$31K | -$21K |
| Net Income Margin | -946.2% | -1288.3% | -1501.8% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Supplementary Data | ||||||||||||||||||
| EPS | -14.57 | -176.60 | -6368.84 | -811.68 | -163968.00 | -5056.00 | -3866.00 | -18064.62 | -54023.02 | -199189.74 | -511212.77 | -511407.41 | -375310.34 | -945000.00 | -578352.17 | -1964470.00 | -30867.00 | -21134.00 |
| Diluted EPS | -14.57 | -176.60 | -6368.84 | -811.68 | -163968.00 | -5056.00 | -3866.00 | -18064.62 | -54023.02 | -199189.74 | -511212.77 | -511407.41 | -375310.34 | -945000.00 | -578352.17 | -1964470.00 | -30867.00 | -21134.00 |
| Weighted Average OS | 8.51M | 2.26M | 1.83M | 3.07M | 563 | 2.56M | 804,200 | 162,500 | 39,100 | 19,500 | 9,400 | 5,400 | 2,900 | 1,000 | 600 | 100 | 100 | 100 |
| EBITDA | -$122.01M | -$74.32M | -$112.37M | -$108.97M | -$92.24M | -$50.44M | -$28.8M | -$26.27M | -$21.22M | -$38.76M | -$48M | -$27.62M | -$10.87M | -$6.65M | -$3.37M | -$1.92M | -$31K | -$21K |
| EBITDA Margin | -930.9% | -736.3% | -1446.5% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 |
| Assets | ||||||||||||||||||
| Current Assets | ||||||||||||||||||
| Cash and Cash Equivalents | $207.64M | $98.78M | $24.95M | $120.23M | $178.66M | $77.07M | $11.25M | $25.03M | $25.5M | $18.94M | $19.18M | $38.18M | $8.2M | $1.79M | $41K | $5K | $13K | $40K |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $7.18M | $23.84M | $0 | $0 | $0 | $0 | $0 | $425 | $5K |
| Cash and Short-Term Investments | $207.64M | $98.78M | $24.95M | $120.23M | $178.66M | $77.07M | $11.25M | $25.03M | $25.5M | $26.12M | $43.02M | $38.18M | $8.2M | $1.79M | $41K | $5K | $13K | $45K |
| Accounts Receivable | $9.76M | $7.9M | $4.59M | $8.04M | $7.73M | $7.63M | $1.01M | $525K | $0 | $0 | $2.83M | $519K | $0 | $0 | $0 | $0 | $0 | $552 |
| Inventory | $6.01M | $8.41M | $14.15M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $5.47M | $1.46M | $2.43M | $1.23M | $1.18M | $1.66M | $400K | $497K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Current Assets | $228.88M | $119M | $47.77M | $130.78M | $189.05M | $87.99M | $13.95M | $26.06M | $26.44M | $27.14M | $46.36M | $39.04M | $8.63M | $2.01M | $144K | $5K | $13K | $46K |
| Long-Term Assets | ||||||||||||||||||
| Property, Plant & Equipment Net | $46M | $42.82M | $94.85M | $94.53M | $51.47M | $9.83M | $390K | $43K | $91K | $150K | $350K | $328K | $45K | $47K | $26K | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $965K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $120K | $120K | $9.74M | $120K | $120K | $120K | $0 | $120K | $120K | $120K | $120K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $2.17M | $904K | $0 | $0 | $240K | $240K | $0 | $100K | $89K | $89K | $189K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | -$240K | -$240K | $0 | -$100K | -$89K | -$89K | -$189K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $0 | $47K | $1.13M | $264K | $259K | $245K | $100K | $100K | $100K | $100K | $189K | $178K | $60K | $60K | $256K | $0 | $0 | $0 |
| Total Long-Term Assets | $48.3M | $43.89M | $106.69M | $94.91M | $51.85M | $10.19M | $610K | $263K | $311K | $370K | $659K | $506K | $105K | $107K | $282K | $0 | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $277.17M | $162.89M | $154.46M | $225.69M | $240.9M | $98.18M | $14.56M | $26.32M | $26.75M | $27.51M | $47.02M | $39.54M | $8.74M | $2.12M | $425K | $5K | $13K | $46K |
| Liabilities | ||||||||||||||||||
| Current Liabilities | ||||||||||||||||||
| Accounts Payable | $8.11M | $4.55M | $3.78M | $8.07M | $13.28M | $4.6M | $3.07M | $1.4M | $1.3M | $872K | $3.05M | $1.49M | $765K | $825K | $695K | $318K | $988 | $0 |
| Short-Term Debt | $0 | $0 | $2.35M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $280K | $0 | $150K | $0 | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $3.42M | $1.82M | $2.98M | $3.27M | $2.83M | $2.17M | $704K | $475K | $519K | $504K | $2.25M | $0 | $0 | $0 | $49K | $0 | $0 | $0 |
| Other Current Liabilities | $11.26M | $7.32M | $5.14M | $3.65M | $2.25M | $452K | $690K | $0 | $0 | $0 | $0 | $1.47M | $0 | $0 | $32K | $0 | $0 | $3K |
| Total Current Liabilities | $30.84M | $18.31M | $18.88M | $18.18M | $21.72M | $9.82M | $5.13M | $2.65M | $2.13M | $2.12M | $6.65M | $3.38M | $2.21M | $1.14M | $925K | $10K | $988 | $3K |
| Long-Term Liabilities | ||||||||||||||||||
| Long-Term Debt | $0 | $4.67M | $6.56M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $1.93M | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $12K | $33K | $106K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $0 | $22.86M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $68K | $13K | $0 | $29K | $0 | $0 | $0 |
| Total Long-Term Liabilities | $1.18M | $5.03M | $30.05M | $328K | $467K | $716K | $6K | $0 | $12K | $33K | $106K | $68K | $13K | $20K | $1.95M | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $32.02M | $23.33M | $48.93M | $18.51M | $22.18M | $10.54M | $5.14M | $2.65M | $2.14M | $2.15M | $6.76M | $3.45M | $2.22M | $1.16M | $2.88M | $10K | $988 | $3K |
| Stockholders' Equity | ||||||||||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $13K | $4K | $59K | $12K | $496K | $206K | $9K | $3K | $8K | $4K | $19K | $11K | $6K | $43K | $27K | $6K | $6K | $6K |
| Retained Earnings | -$854.72M | -$730.69M | -$600.66M | -$470.04M | -$359.82M | -$267.53M | -$217.07M | -$188.45M | -$162.36M | -$141.24M | -$102.4M | -$54.34M | -$26.73M | -$15.84M | -$6.39M | -$71K | -$53K | -$22K |
| Comprehensive Income & Other | -$289K | -$255K | -$232K | -$167K | -$92K | -$62K | -$46K | -$41K | -$12K | -$7K | -$17K | $2K | -$1K | -$32K | -$17K | $0 | $0 | $0 |
| Other Stockholders' Equity | $1.1B | $870.25M | $706.12M | $677.21M | $578.04M | $354.98M | $226.48M | $212.11M | $186.97M | $166.6M | $142.64M | $90.42M | $33.23M | $16.76M | $3.91M | $60K | $60K | $60K |
| Total Equity | $245.15M | $139.56M | $105.53M | $207.18M | $218.72M | $87.65M | $9.42M | $23.66M | $24.62M | $25.36M | $40.26M | $36.09M | $6.51M | $959K | -$2.45M | -$6K | $12K | $43K |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $277.17M | $162.89M | $154.46M | $225.69M | $240.9M | $98.18M | $14.56M | $26.32M | $26.75M | $27.51M | $47.02M | $39.54M | $8.74M | $2.12M | $425K | $5K | $13K | $46K |
| Supplementary Data | ||||||||||||||||||
| Total Debt | $1.31M | $5.3M | $9.81M | $760K | $956K | $1.31M | $358K | $0 | $0 | $0 | $0 | $0 | $280K | $0 | $2.08M | $0 | $0 | $0 |
| Net Debt | -$206.33M | -$93.48M | -$15.13M | -$119.47M | -$177.7M | -$75.76M | -$10.89M | -$25.03M | -$25.5M | -$18.94M | -$19.18M | -$38.18M | -$7.92M | -$1.79M | $2.03M | -$5K | -$13K | -$40K |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 |
| Operating Activities | ||||||||||||||||||
| Net Income | -$124.02M | -$130.04M | -$116.66M | -$110.22M | -$92.29M | -$50.46M | -$28.62M | -$26.09M | -$21.12M | -$38.84M | -$48.05M | -$27.62M | -$10.88M | -$9.45M | -$3.47M | -$1.96M | -$31K | -$21K |
| Depreciation & Amortization | $1.93M | $3.42M | $4.29M | $1.25M | $50K | $27K | $26K | $54K | $70K | $206K | $161K | $36K | $17K | $14K | $9K | $4K | $0 | $0 |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $1.18M | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $6.02M | $4.78M | $9.28M | $10.91M | $7.9M | $2.88M | $1.46M | $1.63M | $1.79M | $3.27M | $4.39M | $3.09M | $1.72M | $865K | $436K | $140K | $0 | $0 |
| Changes in Working Capital: | ||||||||||||||||||
| Accounts Receivable | -$2.62M | -$3.68M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $1.73M | $3.74M | $61K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | $2.99M | $927K | -$3.49M | -$1.04M | $3.53M | $1.53M | $1.66M | $106K | $424K | -$2.19M | $1.58M | $728K | -$60K | $131K | $377K | $294K | $988 | $0 |
| Other Working Capital | $6.44M | $4.79M | $3.39M | $1.04M | $2.25M | -$3.89M | -$1.21M | $331K | -$289K | $107K | -$607K | $316K | $642K | $136K | -$43K | -$2K | $2K | -$2K |
| Total Working Capital Change | $8.54M | $5.78M | -$35K | -$2K | $5.78M | -$2.37M | $452K | $437K | $135K | -$2.08M | $976K | $1.04M | $582K | $267K | $334K | $292K | $3K | -$2K |
| Other Non-Cash Items | $7.69M | $55.14M | $1.12M | $0 | $3M | $1.36M | $0 | $1.63M | $0 | $133K | $3.06M | $608K | $51K | $1.41M | $53K | $296K | $0 | $0 |
| Net Cash from Operating | -$99.84M | -$60.92M | -$102M | -$98.05M | -$75.56M | -$48.57M | -$26.68M | -$23.97M | -$19.13M | -$37.31M | -$42.53M | -$22.84M | -$8.52M | -$5.71M | -$2.64M | -$1.23M | -$28K | -$24K |
| Investing Activities | ||||||||||||||||||
| Capital Expenditures | -$3.37M | -$120K | -$7.89M | -$48.15M | -$35.31M | -$8.56M | -$17K | -$6K | -$5K | -$66K | -$238K | -$319K | -$15K | -$36K | -$3K | -$34K | $0 | $0 |
| Acquisitions | $0 | $0 | -$22.17M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $120K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$28.64M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $7.17M | $16.61M | $4.71M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | -$1.16M | $0 | $999K | $0 | $0 | $0 | $0 | -$6K | $7.17M | $45K | -$120K | -$73K | -$15K | -$90 | $3K | -$60K | $0 | $0 |
| Net Cash from Investing | -$4.53M | -$120K | -$29.07M | -$48.15M | -$35.31M | -$8.56M | -$17K | -$6K | $7.17M | $16.59M | -$24.17M | -$392K | -$15K | -$36K | $302 | -$94K | $0 | $0 |
| Financing Activities | ||||||||||||||||||
| Debt Repaid | $9.65M | $2.35M | -$8.94M | - | - | - | - | - | - | - | - | $280K | - | -$560K | -$2M | - | - | - |
| Common Stock Issuance | $237.94M | $140.19M | $18.94M | $94.5M | $212.39M | $108.61M | $5.84M | $12.71M | $18.5M | $20.5M | $47.69M | $47.84M | $10.04M | $6.93M | $612K | $0 | $0 | $50K |
| Common Stock Repurchases | -$13.76M | $0 | -$13.96M | -$47.25M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | -$451K | $0 | -$3.27M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | -$2.97M | $22.6M | $47.25M | $98K | $10.35M | $101K | $3.27M | $14K | $0 | $9K | $53.22M | $14.67M | $0 | $0 | $1.34M | $0 | $0 |
| Net Cash from Financing | $214.53M | $134.87M | $36.52M | $87.84M | $212.49M | $123.11M | $12.92M | $23.54M | $18.52M | $20.5M | $47.69M | $53.22M | $14.95M | $7.49M | $2.61M | $1.39M | $0 | $50K |
| Forex Effect | -$31K | $4K | -$65K | -$74K | -$31K | -$16K | -$4K | -$13K | -$5K | -$11K | -$4K | -$3K | -$1K | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $110.13M | $73.83M | -$94.62M | -$58.43M | $101.59M | $65.96M | -$13.79M | -$451K | $6.55M | -$234K | -$19.01M | $29.98M | $6.42M | $1.74M | -$24K | $64K | -$28K | $26K |
| Supplementary Data | ||||||||||||||||||
| Operating Cash Flow | -$99.84M | -$60.92M | -$102M | -$98.05M | -$75.56M | -$48.57M | -$26.68M | -$23.97M | -$19.13M | -$37.31M | -$42.53M | -$22.84M | -$8.52M | -$5.71M | -$2.64M | -$1.23M | -$28K | -$24K |
| Capital Expenditure | -$3.37M | -$120K | -$7.89M | -$48.15M | -$35.31M | -$8.56M | -$17K | -$6K | -$5K | -$66K | -$238K | -$319K | -$15K | -$36K | -$3K | -$34K | $0 | $0 |
| Free Cash Flow | -$103.21M | -$61.05M | -$109.9M | -$146.2M | -$110.86M | -$57.13M | -$26.7M | -$23.98M | -$19.13M | -$37.38M | -$42.77M | -$23.16M | -$8.53M | -$5.75M | -$2.64M | -$1.27M | -$28K | -$24K |
| Cash at Beginning | $99.68M | $25.85M | $120.47M | $178.9M | $77.31M | $11.35M | $25.13M | $25.59M | $19.03M | $19.18M | $38.18M | $8.2M | $1.78M | $41K | $65K | $1K | $40K | $14K |
| Cash at End | $209.81M | $99.68M | $25.85M | $120.47M | $178.9M | $77.31M | $11.35M | $25.13M | $25.59M | $18.94M | $19.18M | $38.18M | $8.2M | $1.79M | $41K | $65K | $13K | $40K |